Ongoing Clinical Studies

Filter By State

Filter By Disease Site

Name Physician(s)
Bladder

Study of Macroplastique Safety and Effectiveness in the Treatment of Female Stress Urinary Incontinence (ROSE)

Earl J. Gurevitch, MD
Bladder Cancer

Efficacy Study of a Urine DEK ELISA for Diagnosis of Bladder Cancer

Earl J. Gurevitch, MD

A Phase II Randomized Study for Patients with Muscle-Invasive Bladder Cancer Evaluating Transurethral Surgery and Concomitant Chemoradiation by Either BID Irradiation Plus 5-Fluorouracil and Cisplatin or QD Irradiation Plus Gemcitabine Followed by Selective Bladder Preservation and Gemcitabine/Cisplatin Adjuvant Chemotherapy

Steven E. Finkelstein, MD
Michael I. Ghilezan, MD
Alvaro A. Martinez, MD
Larry L. Kestin, MD
Frank A. Vicini, MD

A Phase II Protocol for Patients with Stage T1 Bladder Cancer to Evaluate Selective Bladder Preserving Treatment by Radiation Therapy Concurrent with Radiosensitizing Chemotherapy Following a Thorough Transurethral Surgical Re-Staging

John Vito Antonucci, MD
Steven E. Finkelstein, MD
Jeffrey D. Forman, MD
Michael I. Ghilezan, MD
Larry L. Kestin, MD
Alvaro A. Martinez, MD
Frank A. Vicini, MD
Breast Cancer

Prospective Neo-Adjuvant REGISTRY Trial Linking MammaPrint, Subtyping and Treatment Response: Neoadjuvant Breast Registry - Symphony Trial

Steven E. Finkelstein, MD
David T. Rock, MD

Prospective Registry Of MammaPrint in breast cancer patients with an Intermediate recurrence Score (PROMIS)

David T. Rock, MD

ASBrS Nipple Sparing Mastectomy Registry

David T. Rock, MD

A Phase 2/3, Multi-Center, Open-Label, Randomized Study of Weekly nab-Paclitaxel in combination with Gemcitabine or carboplatin, Compared to Gemcitabine/Carboplatin, as First-Line Treatment in Subjects with ER, PR and HER2 Negative (Triple Negative) Metastatic Breast Cancer

Steven E. Finkelstein, MD